451
|
Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M. Effects of caffeine on human health. FOOD ADDITIVES AND CONTAMINANTS 2003; 20:1-30. [PMID: 12519715 DOI: 10.1080/0265203021000007840] [Citation(s) in RCA: 575] [Impact Index Per Article: 27.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Caffeine is probably the most frequently ingested pharmacologically active substance in the world. It is found in common beverages (coffee, tea, soft drinks), in products containing cocoa or chocolate, and in medications. Because of its wide consumption at different levels by most segments of the population, the public and the scientific community have expressed interest in the potential for caffeine to produce adverse effects on human health. The possibility that caffeine ingestion adversely affects human health was investigated based on reviews of (primarily) published human studies obtained through a comprehensive literature search. Based on the data reviewed, it is concluded that for the healthy adult population, moderate daily caffeine intake at a dose level up to 400 mg day(-1) (equivalent to 6 mg kg(-1) body weight day(-1) in a 65-kg person) is not associated with adverse effects such as general toxicity, cardiovascular effects, effects on bone status and calcium balance (with consumption of adequate calcium), changes in adult behaviour, increased incidence of cancer and effects on male fertility. The data also show that reproductive-aged women and children are 'at risk' subgroups who may require specific advice on moderating their caffeine intake. Based on available evidence, it is suggested that reproductive-aged women should consume </=300 mg caffeine per day (equivalent to 4.6 mg kg(-1) bw day(-1) for a 65-kg person) while children should consume </=2.5 mg kg(-1) bw day(-1).
Collapse
Affiliation(s)
- P Nawrot
- Toxicological Evaluation Section, Chemical Health Hazard Assessment Division, Bureau of Chemical Safety, Food Directorate, Health Canada, Tunney's Pasture, PL 2204D1, Ottawa, Ontario, Canada K1A 0L2.
| | | | | | | | | | | |
Collapse
|
452
|
Lui LY, Stone K, Cauley JA, Hillier T, Yaffe K. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc 2003; 51:38-43. [PMID: 12534843 DOI: 10.1034/j.1601-5215.2002.51007.x] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVES To determine whether the rate of bone loss predicts subsequent cognitive decline independently of baseline bone mass and whether apolipoprotein E (ApoE) genotype explains the association. DESIGN A prospective cohort study. SETTING Clinical centers in Baltimore, Maryland; Minneapolis, Minnesota; Pittsburgh, Pennsylvania; and Portland, Oregon. PARTICIPANTS Four thousand four hundred sixty-two women aged 70 and older (mean = 75.8) participating in the Study of Osteoporotic Fractures. MEASUREMENTS Total hipbone mineral density (BMD) was measured 2 and 6 years after enrollment (mean follow-up = 3.5 years), and expressed as annualized percentage rate of bone change. A modified Mini-Mental State Examination (mMMSE) was administered at 6 and 10 years (mean follow-up = 4.5 years) and defined cognitive decline as a decline of three or more points on repeat mMMSE score. ApoE genotype information was available on 883 women. RESULTS Cognitive decline occurred in 12% of the women with the least bone loss (by quartile), 14% in the second, 16% in the third, and 20% in those with the greatest bone loss. After adjustment for age, education, stroke, functional status, estrogen use, body mass index, and smoking, the results were similar. Those who lost the most BMD were almost 40% more likely than women in the lowest quartile to develop cognitive decline in the multivariate model (odds ratio (OR) = 1.4, 95% confidence interval (CI) = 1.1-1.8). A similar association between hipbone loss and cognitive decline was observed in the multivariate model further adjusting for ApoE e4 (OR = 1.5, 95% CI = 0.8-2.7). CONCLUSIONS Women with more rapid hipbone loss were more likely to develop cognitive decline than those who had lower rate of loss (or who gained bone mass). Differences in functional status, estrogen use, and ApoE did not explain this association. Further investigation is needed to determine the mechanisms that link osteoporosis and cognitive decline.
Collapse
Affiliation(s)
- Li-Yung Lui
- Department of Medicine, University of California at San Francisco, San Francisco, California 94105, USA.
| | | | | | | | | |
Collapse
|
453
|
Kemmler W, Engelke K, Lauber D, Weineck J, Hensen J, Kalender WA. Exercise effects on fitness and bone mineral density in early postmenopausal women: 1-year EFOPS results. Med Sci Sports Exerc 2002; 34:2115-23. [PMID: 12471325 DOI: 10.1097/00005768-200212000-00038] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE To determine the effect of an intense exercise training on physical fitness, coronary heart disease (CHD), bone mineral density (BMD), and parameters related to quality of life in early postmenopausal women with osteopenia. METHODS Fifty-nine fully compliant women (55.1 +/- 3.4 yr) without any medication or illness affecting bone metabolism took part in intensive exercise training (>2 sessions per week); 41 women served as nontraining control. Both groups received calcium and vitamin D (cholecalciferol) up to a maximum of 1500 mg x d(-1) calcium and 500 IU x d(-1) vitamin D. Bone density of the lumbar spine and hip (DXA Hologic QDR 4500), maximum isometric and dynamic strength (Schnell M3, Schnell-Trainer), VO2max (ZAN 600), and quality of life parameters including vasomotor symptoms related to menopause were measured at baseline and after 14 months. RESULTS After 14 months, there were significant differences between exercise and control groups concerning changes of bone density (LS exercise: +1.3%, P < 0.001 vs control: -1.2%, P < 0.001), maximum isometric strength (exercise: +11 to +32% (P < 0.001) vs control: -1.1 to +3.9%), VO2max (exercise: +11% (P < 0.001) vs control: -4% (P < 0.05)), and quality of life parameters (e.g., lower back pain). Dynamic strength (1RM tests) at four exercises, which was assessed in the exercise group only, increased significantly by 15-43% (all P < 0.001). CONCLUSION The intense exercise training program presented here was effective in improving strength, endurance, quality of life parameters, and even BMD in women in their critical early postmenopausal years.
Collapse
Affiliation(s)
- Wolfgang Kemmler
- Institute of Medical Physics, University of Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany.
| | | | | | | | | | | |
Collapse
|
454
|
Ormarsdóttir S, Ljunggren O, Mallmin H, Olsson R, Prytz H, Lööf L. Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well-preserved liver function. J Intern Med 2002; 252:537-41. [PMID: 12472915 DOI: 10.1046/j.1365-2796.2002.01066.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
OBJECTIVES/DESIGN Increased rate of bone loss has been reported in women with primary biliary cirrhosis (PBC) and varying degree of liver dysfunction. Whether bone loss is increased in patients without liver dysfunction is unclear. The aim of this study was to estimate retrospectively the rate of bone loss in postmenopausal women with PBC and well-preserved liver function. SUBJECTS/INTERVENTIONS Forty-three women with PBC, and classified as Child-Pugh class A, were included. Bone mineral density (BMD) was measured by dual energy X-ray absorptiometry at the lumbar spine and the femoral neck. RESULTS Median time between measurements of BMD was 26 months (range, 12-48 months). Twenty women were not receiving any bone protective treatment, i.e. hormone replacement therapy (HRT), bisphosphonates or vitamin D/calcium supplementation, whilst 23 women received such treatment. Mean annual bone loss in the former group was 0.38 +/- 2.56% and 0.42 +/- 2.29% at the lumbar spine and the femoral neck, respectively. Women receiving treatment, however, increased their BMD by 1.92 +/- 3.76% and 0.15 +/- 2.75% at the lumbar spine and the femoral neck, respectively. At the lumbar spine the difference with regard to changes in BMD between untreated and treated women was statistically significant (P = 0.02). Women who received HRT (n = 11) increased their BMD at the lumbar spine by 2.95 +/- 3.91%, P = 0.03 when compared with untreated women. CONCLUSION Bone loss in postmenopausal women with PBC and well-preserved liver function is not increased above normal. Treatment with bone protective treatment, mainly HRT, improves BMD at the lumbar spine.
Collapse
Affiliation(s)
- S Ormarsdóttir
- Institution for Medical Sciences and Surgical Sciences, University Hospital, Uppsala, Sweden.
| | | | | | | | | | | |
Collapse
|
455
|
Nakamura K, Nashimoto M, Matsuyama S, Hatakeyama M, Yamamoto M. Correlates of bone mineral density in elderly women living in nursing homes for the disabled in Japan. Aging Clin Exp Res 2002; 14:485-90. [PMID: 12674489 DOI: 10.1007/bf03327349] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
BACKGROUND AND AIMS Characteristics of bone aging in the institutionalized elderly are not well known. The aim of this study was to determine the factors correlated with the forearm bone mineral density (BMD) in elderly women with disability. METHODS Of 175 female residents living in nursing homes for the disabled in Niigata, Japan, 119 agreed to participate and underwent medical examinations in 1999; 107 (age range, 66-100) met our inclusion criteria. We measured forearm BMD by dual-energy X-ray absorptiometry (DXA), and the serum concentrations of 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3, intact parathyroid hormone, albumin, total protein, and creatinine. Body weight, score of activities of daily living, and history of femoral neck fractures were also recorded. RESULTS Forearm BMD decreased with age, and the regression equation was BMD=0.9035exp (-0.0179Age) (R2=0.170, p<0.0001). Multiple linear regression analysis revealed that only age (R2=0.178, p<0.0001), and serum creatinine (R2=0.153, p<0.0001) and albumin (R2=0.051, p=0.005) concentrations were independently associated with log-BMD. Twenty-five of the 107 subjects had a history of femoral neck fracture, and only serum albumin concentration (p=0.031) was shown to be associated with fracture history. CONCLUSIONS Forearm BMD was associated with age, serum creatinine and albumin, which may be useful parameters for assessing the bone health of elderly women with disability.
Collapse
Affiliation(s)
- Kazutoshi Nakamura
- Department of Community Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
| | | | | | | | | |
Collapse
|
456
|
Abstract
Caffeine-containing beverage consumption has been reported to be associated with reduced bone mass and increased fracture risk in some, but not most, observational studies. Human physiological studies and controlled balance studies show a clear but only a very small depressant effect of caffeine itself on intestinal calcium absorption, and no effect on total 24-h urinary calcium excretion. The epidemiologic studies showing a negative effect may be explained in part by an inverse relationship between consumption of milk and caffeine-containing beverages. Low calcium intake is clearly linked to skeletal fragility, and it is likely that a high caffeine intake is often a marker for a low calcium intake. The negative effect of caffeine on calcium absorption is small enough to be fully offset by as little as 1-2 tablespoons of milk. All of the observations implicating caffeine-containing beverages as a risk factor for osteoporosis have been made in populations consuming substantially less than optimal calcium intakes. There is no evidence that caffeine has any harmful effect on bone status or on the calcium economy in individuals who ingest the currently recommended daily allowances of calcium.
Collapse
Affiliation(s)
- R P Heaney
- Creighton University, 2500 California Plaza, Omaha, Nebraska 68178, USA.
| |
Collapse
|
457
|
Huang MH, Schocken M, Block G, Sowers M, Gold E, Sternfeld B, Seeman T, Greendale GA. Variation in nutrient intakes by ethnicity: results from the Study of Women's Health Across the Nation (SWAN). Menopause 2002; 9:309-19. [PMID: 12218719 DOI: 10.1097/00042192-200209000-00003] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To use food frequency questionnaires to summarize the macro- and micronutrient intakes of women of diverse ethnicity in the Study of Women's Health Across the Nation. DESIGN The Study of Women's Health Across the Nation is a multisite, multiethnic, community-based, longitudinal study of midlife women at seven geographic locations in the USA. The cohort is made up of participants with African, Caucasian, Chinese, Hispanic, and Japanese ethnic backgrounds. The Block Food Frequency Questionnaire was modified to accommodate ethnic-specific diets and was administered by interview. Descriptive statistics for macro- and micronutrient intakes were calculated, and variation in nutrient intakes by ethnic group was assessed using multivariable models, with Bonferonni correction for multiple comparisons. RESULTS The crude and energy-adjusted distributions of all 28 nutrients studied differed statistically by ethnicity ( < 0.001). In many cases the magnitude of the variation was small. For example, the difference between the highest and lowest mean energy intakes was approximately 135 kcal (African American vs. Hispanic). Other differences were substantial: the energy-adjusted total fat intake in Chinese women was at least 10% lower than all other ethnic groups except the Japanese women (all pair-wise comparisons; < 0.01). CONCLUSIONS Knowledge of variation in nutrient intake is critical to the understanding of how diet and health are related. The broad range of nutrient intakes reported by these participants will permit exploration of the associations between diet, menopause, and health and consideration of the role of dietary factors in explaining health-related differences among women of diverse ethnicity.
Collapse
Affiliation(s)
- Mei-Hua Huang
- Division of Geriatrics, School of Medicine, University of California, Los Angeles, Los Angeles 90095-1687, California, USA.
| | | | | | | | | | | | | | | |
Collapse
|
458
|
Holm K, Dan A, Wilbur J, Li S, Walker J. A longitudinal study of bone density in midlife women. Health Care Women Int 2002; 23:678-91. [PMID: 12418988 DOI: 10.1080/07399330290107421] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
A longitudinal study of 386 healthy Black and White women aged 35-60 years was conducted to determine the effects of physical activity and other related factors on lumbar bone mineral density over 24 months. Bone mineral density of the lumbar spine, L2-L4, was measured using dual energy x-ray (Hologic 1000). Physical activity levels in three dimensions (leisure, household, and occupational) from both a lifelong and current perspective were obtained by questionnaire. Body mass index was calculated from measured weight in kilograms divided by measured height in meters squared. Calcium, caffeine, and alcohol intake was estimated using a food frequency questionnaire. Age, race, and smoking were determined by self-report. Radioimmunoassays of follicle stimulating hormone (FSH) and estradiol were used to validate self-reports of menopausal status. Multiple regression analysis revealed that race, age, weight, FSH, calcium, and years of tobacco intake formed the best model at baseline (r(2) = 0.32) and at 24 months (r(2) = 0.303). Physical activity was not a significant predictor for bone mineral density at either time point. There were cross-sectional changes of bone mineral density with race, age, and menopausal status. Black women had significantly higher bone mineral density than White women. However, an age-related decline in bone mineral density was exhibited in both Black and White women. Perimenopausal women had significantly lower bone mineral density as compared with premenopausal women. Furthermore 37 (9.6%) women at baseline and 34 (11%) at 24 months were designated at risk for fracture.
Collapse
Affiliation(s)
- Karyn Holm
- Department of Nursing, DePaul University, Chicago, Illinois 60614, USA.
| | | | | | | | | |
Collapse
|
459
|
Karasik D, Myers RH, Cupples LA, Hannan MT, Gagnon DR, Herbert A, Kiel DP. Genome screen for quantitative trait loci contributing to normal variation in bone mineral density: the Framingham Study. J Bone Miner Res 2002; 17:1718-27. [PMID: 12211443 DOI: 10.1359/jbmr.2002.17.9.1718] [Citation(s) in RCA: 92] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
A genome-wide scan was performed in a randomly ascertained set of 330 extended families from the population-based Framingham Study to identify chromosomal regions possibly linked to bone mineral density (BMD). A set of 401 microsatellite markers was typed at a 10-centimorgan (cM) average density throughout the genome. BMD was measured at the femoral neck, trochanter, Ward's area, and lumbar spine in 1557 participants of both Framingham cohorts. BMDs were adjusted for age, body mass index (BMI), height, alcohol, caffeine, calcium and vitamin D intakes, smoking, physical activity, and estrogen use in women within each sex and cohort. Strong heritabilities (values between 0.543 and 0.633) were found for the adjusted BMD at all sites. Two-point and multipoint quantitative linkage analyses were performed for each BMD site using the maximum likelihood variance components method. By two-point screening, loci of suggestive linkage were identified on chromosomes 6 and 21, with the maximum log10 of the odds ratio (LOD) scores of 2.34 for the trochanter at D21S1446 and 2.93 for the femoral neck at D6S2427. Lumbar spine BMD had maxima at D6S2427 (LOD = 1.88) and at D12S395 (LOD = 2.08). Multipoint linkage analysis revealed suggestive linkage of trochanteric BMD at a broad (approximately 20 cM) interval on chromosome 21q, with the peak linkage close to D21S1446 (LOD = 3.14). LOD scores were 2.13 at 8q24 with Ward's BMD and 1.92 at 14q21.3 with lumbar spine BMD. This largest genome screen to date for genes underlying normal variation in BMD, adjusted for a large number of covariates, will help to identify new positional candidate genes, otherwise unrecognized.
Collapse
Affiliation(s)
- D Karasik
- Hebrew Rehabilitation Center for Aged and Harvard Medical School, Boston, Massachusetts 02131, USA
| | | | | | | | | | | | | |
Collapse
|
460
|
Abstract
Osteoporosis is a major clinical problem in older women and men. Almost any bone can fracture as a result of the increased bone fragility of osteoporosis. These fractures are associated with higher health care costs, physical disability, impaired quality of life, and increased mortality. Because the incidence of osteoporotic fracture increases with advancing age, measures to diagnose and prevent osteoporosis and its complications assume a major public health concern. BMD is a valuable tool to identify patients at risk for fracture, to make therapeutic decisions, and to monitor therapy. Several other modifiable and nonmodifiable risk factors for osteoporosis have also been identified. Treatment of potentially modifiable risk factors along with exercise and calcium and vitamin D supplementation forms an important adjunct to pharmacologic management of osteoporosis. Improved household safety can reduce the risk of falls. Hip protectors have been found to be effective in nursing home population. The pharmacologic options include bisphosphonates, HRT, SERMs and calcitonin. PTH had received FDA advisory committee approval. Alendronate has been approved for treatment of osteoporosis in men, and other treatments for men are under evaluation.
Collapse
Affiliation(s)
- Manish Srivastava
- Section of Geriatric Medicine, A91 Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
| | | |
Collapse
|
461
|
BERRUTI ALFREDO, DOGLIOTTI LUIGI, TERRONE CARLO, CERUTTI STEFANIA, ISAIA GIANCARLO, TARABUZZI ROBERTO, REIMONDO GIUSEPPE, MARI MAURO, ARDISSONE PAOLA, DE LUCA STEFANO, FASOLIS GIUSEPPE, FONTANA DARIO, ROCCA ROSSETTI SALVATORE, ANGELI ALBERTO. Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy. J Urol 2002. [DOI: 10.1016/s0022-5347(05)64985-3] [Citation(s) in RCA: 211] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- ALFREDO BERRUTI
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - LUIGI DOGLIOTTI
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - CARLO TERRONE
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - STEFANIA CERUTTI
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - GIANCARLO ISAIA
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - ROBERTO TARABUZZI
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - GIUSEPPE REIMONDO
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - MAURO MARI
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - PAOLA ARDISSONE
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - STEFANO DE LUCA
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - GIUSEPPE FASOLIS
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - DARIO FONTANA
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - SALVATORE ROCCA ROSSETTI
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | - ALBERTO ANGELI
- From the Department of Clinical and Biological Sciences, University of Torino at San Luigi Hospital, Orbassano, Medical Oncology, Internal Medicine, Urology, Department of Internal Medicine and Urology, University of Torino at San Giovanni Battista Hospital, Torino, and Urology San Lazzaro Hospital, Alba, Italy
| | | |
Collapse
|
462
|
Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy. J Urol 2002. [DOI: 10.1097/00005392-200206000-00006] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
463
|
|
464
|
Westman EC. Is dietary carbohydrate essential for human nutrition? Am J Clin Nutr 2002; 75:951-3; author reply 953-4. [PMID: 11976176 DOI: 10.1093/ajcn/75.5.951] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
|
465
|
Hui SL, Perkins AJ, Zhou L, Longcope C, Econs MJ, Peacock M, McClintock C, Johnston CC. Bone loss at the femoral neck in premenopausal white women: effects of weight change and sex-hormone levels. J Clin Endocrinol Metab 2002; 87:1539-43. [PMID: 11932278 DOI: 10.1210/jcem.87.4.8393] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
To investigate whether bone loss occurs in the premenopause, we measured the bone mineral content (BMC), bone mineral density (BMD), and bone area in the spine (L2-L4), femoral neck, and total hip, as well as the sex hormone levels of 130 healthy premenopausal white women (age, 31-50 yr) at least three times over 1-9 yr. We found an increase in all three bone measurements at the spine but no change in volumetric density. Neither could we detect any age-related changes in any of the three measurements in the total hip. In contrast, we detected a significant decrease in femoral neck BMD over time, due to a decrease in BMC and increase in bone area. Greater loss in femoral neck BMD was associated independently with weight loss and lower levels of estrone sulfate or E2. Separating the women into those with FSH spikes (>20 IU/liter) and women with consistently low FSH, we found the latter group had smaller decrease in BMD and that the decrease was due less to a decline in BMC and more to an increase in bone area. In summary, femoral neck BMD decreases in premenopausal women, particularly those with lower levels of estrogens resulting from slowing ovarian function despite regular menses. This decrease can be offset by more rapid weight gain.
Collapse
Affiliation(s)
- Siu L Hui
- Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
| | | | | | | | | | | | | | | |
Collapse
|
466
|
Naganathan V, Macgregor A, Snieder H, Nguyen T, Spector T, Sambrook P. Gender differences in the genetic factors responsible for variation in bone density and ultrasound. J Bone Miner Res 2002; 17:725-33. [PMID: 11918230 DOI: 10.1359/jbmr.2002.17.4.725] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Although genetic factors are thought to explain a large proportion of the variation in bone density in women, few studies have been conducted in men. Therefore, it is unclear whether the individual differences in bone strength between men and women are a reflection of gender differences in the relative influence of genetic and environmental factors on bone density variance. The aim of this study was to determine if there were gender differences in the genetic components of variance for bone density and ultrasound. In addition, the study aimed to explore the hypothesis that there are unique gender-specific genetic determinants of these traits. Bone mineral density (BMD) of the hip, distal forearm, and lumbar spine were measured by dual-energy X-ray absorptiometry (DXA) as well as quantitative ultrasound (QUS) at the calcaneus in healthy female twin pairs (286 identical [MZ] and 265 nonidentical [DZ]), male twin pairs (72 MZ and 65 DZ), and 82 opposite-sex (OS) pairs aged between 18 and 80 years. For hip BMD, distal forearm, and QUS measurements, the differences between MZ correlations and like-sex DZ correlations were similar for both sexes, suggesting little difference in the component of total variance explained by genetic factors between male and female twin pairs. However, correlations between OS twin pairs were lower than that of like-sex twin pairs, suggesting the possibility of unique gender-specific genetic effects. At the forearm, model fitting suggested a small gender difference in the magnitude of genetic variance as well as the presence of a unique gender-specific genetic variance component. Hip, lumbar spine, and QUS measurements were better explained by models that assumed no gender differences in genetic variance between the sexes, but the study had insufficient power to detect small differences in the genetic components of variance. The results of this study suggest that the proportion of bone strength variance explained by genetic factors is similar for men and women. However, at some regions there is evidence to suggest a gender-specific genetic component to the overall genetic variance.
Collapse
Affiliation(s)
- Vasi Naganathan
- Institute of Bone and Joint Research, Department of Rheumatology, Royal North Shore Hospital, Sydney, Australia
| | | | | | | | | | | |
Collapse
|
467
|
Ormarsdóttir S, Ljunggren O, Mallmin H, Michaëlsson K, Lööf L. Increased rate of bone loss at the femoral neck in patients with chronic liver disease. Eur J Gastroenterol Hepatol 2002; 14:43-8. [PMID: 11782574 DOI: 10.1097/00042737-200201000-00008] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
OBJECTIVE Patients with chronic liver disease (CLD) have an increased prevalence of osteoporosis. The aim of this study was to evaluate prospectively the rate of bone loss and potential predictors of increased bone loss in a cohort of patients with CLD. DESIGN Bone mineral density (BMD) was measured at baseline and at follow-up by dual-energy X-ray absorptiometry at the lumbar spine and the femoral neck. RESULTS Forty-three patients (31 female, 12 male) were available for a second measurement of BMD, with a median of 25 months (range 18-41) between the measurements. Mean annual bone loss at the lumbar spine and the femoral neck, respectively, was 0.6 +/- 2.0% and 1.5 +/- 2.4% in females and 0.8 +/- 1.9% and 2.9 +/- 2.0% in males. The BMD Z score decreased significantly over time at the femoral neck (P = 0.005 and P = 0.02 for females and males, respectively). Bone loss was increased significantly at the lumbar spine in patients classified as Child-Pugh B + C compared with those classified as Child-Pugh A (P = 0.04). Serum levels of bilirubin correlated independently and positively, and 25-hydroxy vitamin D3 levels negatively, with bone loss at the femoral neck. CONCLUSIONS Patients with CLD have increased bone loss at the femoral neck. Advanced liver disease is associated with increased bone loss, and hyperbilirubinaemia and low levels of vitamin D3 are predictors of increased bone loss.
Collapse
Affiliation(s)
- Sif Ormarsdóttir
- Department of Internal Medicine, University Hospital, Uppsala, Sweden.
| | | | | | | | | |
Collapse
|
468
|
Abstract
Although high calcium intakes have long been recommended to prevent osteoporosis, there is little evidence that high calcium intakes effectively prevent fractures. Osteoporotic fractures are, like coronary artery disease, largely a disease of Western societies. Recent evidence that the statins that block the mevalonate pathway, lower serum cholesterol concentrations, and improve cardiovascular disease risk also prevent fractures, together with the increasing evidence that diets high in fruit and vegetables are beneficial in preventing fractures, suggest common dietary etiologic factors. Further research in this area should answer the long-standing question: Why do populations who consume low-calcium diets have fewer fractures than do Western societies who consume high-calcium diets?
Collapse
|
469
|
Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 2001; 74:694-700. [PMID: 11684540 DOI: 10.1093/ajcn/74.5.694] [Citation(s) in RCA: 165] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND The role of caffeine as a risk factor for bone loss is controversial. OBJECTIVE Our goals were 1) to compare in both a cross-sectional study and a 3-y longitudinal study the bone mineral density (BMD) of postmenopausal women consuming high or low amounts of caffeine and 2) to study the interaction between caffeine intake, vitamin D receptor (VDR) polymorphism, and BMD in the longitudinal study. DESIGN The results are derived from cross-sectional measurements of BMD in 489 elderly women (aged 65-77 y) and from longitudinal measurements made in 96 of these women who were treated with a placebo for 3 y. Changes in BMD were adjusted for confounding factors and were compared between groups with either low (< or =300 mg/d) or high (>300 mg/d) caffeine intakes and between the VDR genotype subgroups of the low- and high-caffeine groups. RESULTS Women with high caffeine intakes had significantly higher rates of bone loss at the spine than did those with low intakes (-1.90 +/- 0.97% compared with 1.19 +/- 1.08%; P = 0.038). When the data were analyzed according to VDR genotype and caffeine intake, women with the tt genotype had significantly (P = 0.054) higher rates of bone loss at the spine (-8.14 +/- 2.62%) than did women with the TT genotype (-0.34 +/- 1.42%) when their caffeine intake was >300 mg/d. CONCLUSIONS Intakes of caffeine in amounts >300 mg/d ( approximately 514 g, or 18 oz, brewed coffee) accelerate bone loss at the spine in elderly postmenopausal women. Furthermore, women with the tt genetic variant of VDR appear to be at a greater risk for this deleterious effect of caffeine on bone.
Collapse
Affiliation(s)
- P B Rapuri
- Bone Metabolism Unit, Creighton University, School of Medicine, Omaha, NE 68131, USA.
| | | | | | | |
Collapse
|
470
|
|
471
|
Shapses SA, Von Thun NL, Heymsfield SB, Ricci TA, Ospina M, Pierson RN, Stahl T. Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation. J Bone Miner Res 2001; 16:1329-36. [PMID: 11450709 DOI: 10.1359/jbmr.2001.16.7.1329] [Citation(s) in RCA: 98] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Bone turnover is increased during weight loss in postmenopausal women and can be suppressed with calcium supplementation. In this study, we assessed the influence of energy restriction with and without calcium supplementation (1 g/day) in premenopausal women. Thirty-eight obese premenopausal women (body mass index [BMI] of 35.0 +/- 3.9 kg/m2) completed a 6-month study of either moderate weight loss or weight maintenance. During weight loss, women were randomly assigned to either a calcium supplementation (n = 14) or placebo group (n = 14) and lost 7.5 +/- 2.5% of their body weight. The control group of women (n = 10) maintained their body weight. Total body and lumbar bone mineral density (LBMD) and content were measured by dual-energy X-ray absorptiometry (DXA) at baseline and after weight loss. Throughout the study, blood and urine samples were collected to measure bone turnover markers and hormones. During moderate energy restriction, dietary calcium intake decreased (p < 0.05) and the bone resorption marker deoxypyridinoline (DPD) increased slightly (p < or = 0.05) without evidence of bone loss. Calcium supplementation during weight loss tended to increase lumbar BMD by 1.7% (p = 0.05) compared with the placebo or weight maintenance groups. In contrast to our previous findings in postmenopausal women, premenopausal obese women who consume a low calcium diet do not lose bone over a 6-month period, whether their weight is stable or decreasing moderately.
Collapse
Affiliation(s)
- S A Shapses
- Department of Nutritional Sciences, Rutgers University, New Brunswick, New Jersey 08901-8525, USA
| | | | | | | | | | | | | |
Collapse
|
472
|
Hla MM, Davis JW, Ross PD, Yates AJ, Wasnich RD. The relation between lifestyle factors and biochemical markers of bone turnover among early postmenopausal women. Calcif Tissue Int 2001; 68:291-6. [PMID: 11683536 DOI: 10.1007/bf02390836] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
We examined the associations of two biochemical markers of bone turnover with lifestyle factors in 340 postmenopausal women in Hawaii, ages 45-59 years, from the Early Postmenopausal Intervention Cohort. Physical activity, calcium supplement use, smoking and alcohol use in the prior 2 weeks were measured and examined as independent variables in multiple regression analyses with bone turnover markers as dependent variables, adjusted for weight, height, whole body bone mass, serum estradiol, years since menopause, and ethnicity. Calcium supplement and alcohol use were significantly associated with reduced levels of urinary type I collagen cross-linked N-telopeptides (NTX). The mean NTX level was 12% lower among women using > or = 250 mg of calcium supplements per day as compared with other women, and 20% lower among alcohol users compared with nonusers. Both calcium supplement use and alcohol intake were associated with lower mean serum osteocalcin (a marker of bone formation) and NTX z-scores. By contrast, smoking was associated with lower osteocalcin levels, without any effect on NTX. The osteocalcin level was 12% lower among smokers compared with nonsmokers. In addition, the z-score difference between NTX and osteocalcin was significantly associated with smoking, with a shift towards more NTX than osteocalcin. Physical activity was not significantly associated with either of the markers. These findings suggest that biochemical markers may help to identify lifestyle factors that affect bone, and provide estimates of the relative magnitude of these effects on bone formation and resorption, independent of each other.
Collapse
Affiliation(s)
- M M Hla
- School of Public Health, University of Hawaii, Honolulu, USA
| | | | | | | | | |
Collapse
|
473
|
Abstract
The effects of coffee on bone metabolism are still controversial, although several studies have suggested that caffeine and/or heavy coffee consumption is associated with a significant increase in risk of fracture, osteoporosis, and periodontal disease. Therefore, we sought to clarify the relationship between coffee consumption and bone metabolism using male Wistar rats. Forty-eight male Wistar rats were assigned to three treatment groups including a control-diet group (control, n = 16, coffee-free diet), a 0.62% coffee-diet group (low caffeine, n = 16, diet supplemented with 6.2 g/kg of the control diet), and a 1.36% coffee-diet group (high caffeine, n = 16, diet supplemented with 13.6 g/kg of the control diet), and animals were maintained on an experimental diet for 140 days. Although caffeine in serum was not detected in rats fed the control diet, low-intake coffee for 140 days led to an increase in caffeine concentration to 0.53 +/- 0.11 microg/mL and high-intake coffee led to an increase of 1.77 +/- 0.22 microg/mL. No significant differences in body weight change, serum and urinary biochemical markers of bone metabolism, and bone histomorphometry were found between the coffee-diet groups and the control-diet group, except that urinary phosphorus excretion after 140 days of both coffee diets was significantly increased compared with controls (p < 0.05). In addition, the coffee diets were not associated with differences in tumor necrosis factor-alpha and interleukin-6, which have been implicated in the pathogenesis of bone loss together with interleukin-1beta. In conclusion, the present study strongly indicates that coffee does not stimulate bone loss in rats.
Collapse
Affiliation(s)
- W Sakamoto
- Department of Biochemistry, School of Medicine, Hokkaido University, Sapporo, Japan.
| | | | | | | | | | | | | |
Collapse
|
474
|
Abstract
Although less common than in women, osteoporosis in men is a prevalent worldwide problem with important socioeconomic implications. Our understanding of this condition in men is growing, but there remains a great deal more to be determined. Definitions for osteoporosis in men are needed. Cost-effective guidelines on who should be investigated and treated, and how, are clearly necessary. The role of bone mineral densitometry in diagnosis and treatment decisions needs to be clarified. The efficacy of drug therapies for osteoporosis in men requires greater attention. Currently, a large multicenter study is underway in the United States and should provide much needed insight into the epidemiology of osteoporosis in men.
Collapse
Affiliation(s)
- S Amin
- Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
| | | |
Collapse
|
475
|
Abstract
The present review addresses the relative contribution of diet and genotype to variability in human bone growth and mineralisation in the context of the aetiology of osteoporosis. Heritability studies indicate that 60-70 % of the variability in bone mineral mass or bone mineral density (BMD) can be accounted for by genetic variation. Cross-trait analyses suggest that a proportion of this variation reflects genetic influences on bone and body size, such as height and lean body mass. Candidate-gene studies have demonstrated associations between several genetic polymorphisms and bone mineral mass but, as yet, genotype determinations have proved unhelpful in identifying individuals at increased risk of osteoporosis. Variations in diet and other environmental factors contribute 30-40 % to total phenotypic variance in bone mineral mass or BMD. Correlations between intakes of individual nutrients and BMD have been reported, but these relationships are subject to confounding due to size. However, no specific dietary factor has been identified from prospective and twin studies as making a significant contribution to environmental variability in BMD or bone loss. This finding may reflect the difficulties in quantifying environmental exposures. both current and over a lifetime. In addition, the influence of diet on bone health may depend on the genotype of the individual. Optimisation of nutrition and lifestyle remains an attractive strategy for the reduction of fracture risk, but more research is required to fully define optimal dietary requirements.
Collapse
Affiliation(s)
- A Prentice
- MRC Human Nutrition Research, Cambridge, UK.
| |
Collapse
|
476
|
|
477
|
Hannan MT, Tucker KL, Dawson-Hughes B, Cupples LA, Felson DT, Kiel DP. Effect of dietary protein on bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 2000; 15:2504-12. [PMID: 11127216 DOI: 10.1359/jbmr.2000.15.12.2504] [Citation(s) in RCA: 314] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Few studies have evaluated protein intake and bone loss in elders. Excess protein may be associated with negative calcium balance, whereas low protein intake has been associated with fracture. We examined the relation between baseline dietary protein and subsequent 4-year change in bone mineral density (BMD) for 391 women and 224 men from the population-based Framingham Osteoporosis Study. BMD (g/cm2) was assessed in 1988-1989 and in 1992-1993 at the femur, spine, and radius. Usual dietary protein intake was determined using a semiquantitative food frequency questionnaire (FFQ) and expressed as percent of energy from protein intake. BMD loss over 4 years was regressed on percent protein intake, simultaneously adjusting for other baseline factors: age, weight, height, weight change, total energy intake, smoking, alcohol intake, caffeine, physical activity, calcium intake, and, for women, current estrogen use. Effects of animal protein on bone loss also were examined. Mean age at baseline (+/-SD) of 615 participants was 75 years (+/-4.4; range, 68-91 years). Mean protein intake was 68 g/day (+/-24.0; range, 14-175 g/day), and mean percent of energy from protein was 16% (+/-3.4; range, 7-30%). Proportional protein intakes were similar for men and women. Lower protein intake was significantly related to bone loss at femoral and spine sites (p < or = 0.04) with effects similar to 10 lb of weight. Persons in the lowest quartile of protein intake showed the greatest bone loss. Similar to the overall protein effect, lower percent animal protein also was significantly related to bone loss at femoral and spine BMD sites (all p < 0.01) but not the radial shaft (p = 0.23). Even after controlling for known confounders including weight loss, women and men with relatively lower protein intake had increased bone loss, suggesting that protein intake is important in maintaining bone or minimizing bone loss in elderly persons. Further, higher intake of animal protein does not appear to affect the skeleton adversely in this elderly population.
Collapse
Affiliation(s)
- M T Hannan
- Hebrew Rehabilitation Center for Aged, Research and Training Institute and Harvard Medical School Division on Aging, Boston, Massachusetts 02131-1097, USA
| | | | | | | | | | | |
Collapse
|
478
|
Dai J, Lin D, Zhang J, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin Invest 2000; 106:887-95. [PMID: 11018077 PMCID: PMC381425 DOI: 10.1172/jci10483] [Citation(s) in RCA: 109] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
To investigate the role of IL-6 in alcohol-mediated osteoporosis, we measured a variety of bone remodeling parameters in wild-type (il6(+/+)) or IL-6 gene knockout (il6(-/-)) mice that were fed either control or ethanol liquid diets for 4 months. In the il6(+/+) mice, ethanol ingestion decreased bone mineral density, as determined by dual-energy densitometry; decreased cancellous bone volume and trabecular width and increased trabecular spacing and osteoclast surface, as determined by histomorphometry of the femur; increased urinary deoxypyridinolines, as determined by ELISA; and increased CFU-GM formation and osteoclastogenesis as determined ex vivo in bone marrow cell cultures. In contrast, ethanol ingestion did not alter any of these parameters in the il6(-/-) mice. Ethanol increased receptor activator of NF-kappaB ligand (RANKL) mRNA expression in the bone marrow of il6(+/+) but not il6(-/-) mice. Additionally, ethanol decreased several osteoblastic parameters including osteoblast perimeter and osteoblast culture calcium retention in both il6(+/+) and il6(-/-) mice. These findings demonstrate that ethanol induces bone loss through IL-6. Furthermore, they suggest that IL-6 achieves this effect by inducing RANKL and promoting CFU-GM formation and osteoclastogenesis.
Collapse
Affiliation(s)
- J Dai
- Unit for Laboratory Animal Medicine, University of Michigan, Ann Arbor, Michigan, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|